Pinto, E.; Lazzarini, E.; Pelizzaro, F.; Gambato, M.; Santarelli, L.; Potente, S.; Zanaga, P.; Zappitelli, T.; Cardin, R.; Burra, P.;
et al. Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study. Cancers 2025, 17, 1115.
https://doi.org/10.3390/cancers17071115
AMA Style
Pinto E, Lazzarini E, Pelizzaro F, Gambato M, Santarelli L, Potente S, Zanaga P, Zappitelli T, Cardin R, Burra P,
et al. Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study. Cancers. 2025; 17(7):1115.
https://doi.org/10.3390/cancers17071115
Chicago/Turabian Style
Pinto, Elisa, Elisabetta Lazzarini, Filippo Pelizzaro, Martina Gambato, Laura Santarelli, Sara Potente, Paola Zanaga, Teresa Zappitelli, Romilda Cardin, Patrizia Burra,
and et al. 2025. "Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study" Cancers 17, no. 7: 1115.
https://doi.org/10.3390/cancers17071115
APA Style
Pinto, E., Lazzarini, E., Pelizzaro, F., Gambato, M., Santarelli, L., Potente, S., Zanaga, P., Zappitelli, T., Cardin, R., Burra, P., Farinati, F., Romualdi, C., Boscarino, D., Tosello, V., Indraccolo, S., & Russo, F. P.
(2025). Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study. Cancers, 17(7), 1115.
https://doi.org/10.3390/cancers17071115
